Richard Steinhart
2019
In 2019, Richard Steinhart earned a total compensation of $404K as Chief Financial Officer at BioXcel Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $114,125 |
|---|---|
| Salary | $285,600 |
| Other | $4,272 |
| Total | $403,997 |
Steinhart received $285.6K in salary, accounting for 71% of the total pay in 2019.
Steinhart also received $114.1K in non-equity incentive plan and $4.3K in other compensation.
Rankings
In 2019, Richard Steinhart's compensation ranked 12,313th out of 13,971 executives tracked by ExecPay. In other words, Steinhart earned more than 11.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,313 out of 13,971 | 12th |
Division Manufacturing | 4,985 out of 5,701 | 13th |
Major group Chemicals And Allied Products | 1,963 out of 2,200 | 11th |
Industry group Drugs | 1,689 out of 1,886 | 10th |
Industry Pharmaceutical Preparations | 1,250 out of 1,398 | 11th |
Source: SEC filing on April 6, 2020.
Steinhart's colleagues
We found two more compensation records of executives who worked with Richard Steinhart at BioXcel Therapeutics in 2019.